- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Andrew S. Oseran, MD, MBA, MSc
Andrew S. Oseran, MD, MBA, MSc, is an advanced heart failure and transplant cardiologist at Beth Israel Deaconess Medical Center and an investigator at the Richard A. and Susan F. Smith Center for Outcomes Research.
Articles
Further Research Into Medicare Advantage Upcoding, Documentation Accuracy Needed
February 27th 2025Andrew S. Oseran, MD, MBA, MSc, hypothesizes that higher Medicare Advantage (MA) risk scores may result from either a more accurate capture of beneficiaries' comorbidities or inappropriate "upcoding" of conditions.
Chronic Condition Prevalence Similar in Medicare Advantage, Traditional Medicare Beneficiaries
February 26th 2025The excess payments Medicare Advantage plans receive for higher risk scores may be more influenced by differences in coding practices rather than actual differences in disease burden between MA and fee-for-service Medicare beneficiaries, according to Andrew, S. Oseran, MD, MBA, MSc, of Beth Israel Deaconess Medical Center.
Unpacking Medicare Advantage Criticism With Dr Andrew S. Oseran
February 25th 2025Medicare Advantage (MA) plans, with fixed payments based on medical complexity, incentivize aggressive coding of comorbidities, potentially inflating costs for the federal government, according to Andrew S. Oseran, MD, MBA, MSc, of Beth Israel Deaconess Medical Center.
